Clinical trials
Phase 3 Depressive Disorder trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 3 |
| 2002 | 3 |
| 2004 | 1 |
| 2005 | 5 |
| 2006 | 5 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 2 |
| 2011 | 5 |
| 2012 | 2 |
| 2014 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2025 | 1 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 31 |
| Recruiting | 3 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sanofi | 6 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 5 |
| Eli Lilly and Company | 3 |
| Takeda | 3 |
| Wyeth is now a wholly owned subsidiary of Pfizer | 3 |
| National Center for Complementary and Integrative Health (NCCIH) | 2 |
| Axsome Therapeutics, Inc. | 1 |
| Biogen | 1 |
| Cybin IRL Limited | 1 |
| Hadassah Medical Organization | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Depressive Disorder | 35 |
| Major Depressive Disorder | 24 |
| Mood Disorders | 9 |
| Mental Disorders | 5 |
| Dysthymic Disorder | 2 |
| Affective Disorders, Psychotic | 1 |
| Bipolar Disorder | 1 |
| Blindness | 1 |
| Depressive Disorder, Treatment-Resistant | 1 |
| Diabetic Neuropathies | 1 |
Trials
Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.